Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 18/20 | 0.44 |
| ▸ | ITGA2B | P08514 | 11/20 | 0.44 |
| ▸ | ITGAV | P06756 | 8/20 | 0.43 |
| ▸ | ITGB1 | P05556 | 2/20 | 0.41 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.41 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7463784 | 0.96 | ITGB3 (0.48) | ITGB3ITGA2BITGAVITGB1ITGA5 | |
| Trifluoroacetic Acid SCHEMBL7415214 | 0.95 | ITGB3 (0.45) | ITGB3ITGA2BITGAVITGB1ITGA5 | |
| SCHEMBL7419721 | 0.91 | ITGB3 (0.48) | ITGB3ITGA2BITGAVITGB1ITGA5 | |
| Trifluoroacetic Acid SCHEMBL7422529 | 0.90 | ITGB3 (0.51) | ITGB3ITGA2BITGAVITGB1ITGA5 | |
| SCHEMBL7415329 | 0.90 | ITGB3 (0.35) | ITGB3ITGA2BITGAVITGB1ITGA5 | |
| Trifluoroacetic Acid SCHEMBL7408417 | 0.89 | ITGB1 (0.47) | ITGB3ITGA2BITGAVITGB1ITGA5 | |
| Trifluoroacetic Acid SCHEMBL7416599 | 0.88 | ITGB3 (0.47) | ITGB3ITGA2BITGAVITGB1ITGA5 | |
| Trifluoroacetic Acid SCHEMBL7415321 | 0.88 | ITGB1 (0.49) | ITGB3ITGA2BITGAVITGB1ITGA5 | |
| Trifluoroacetic Acid SCHEMBL7417558 | 0.87 | ITGB3 (0.49) | ITGB3ITGA2BITGAVCHRM2SLC6A4 | |
| Trifluoroacetic Acid SCHEMBL7408388 | 0.87 | ITGB3 (0.47) | ITGB3ITGA2BITGAVITGB1ITGA5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6344484-B1 | TREATMENT OF TUMOR GROWTH, METASTASIS, OSTEOPOROSIS, RESTENOSIS, INFLAMMATION, MACULAR DEGENERATION, DIABETIC RETINOPATHY, AND RHEUMATOID ARTHRITIS | 3-DIMENSIONAL PHARMACEUTICALS, INC. | 2002-02-05 | — | — | US | disclosed |
| EP-1159262-A1 | TYROSINE ALKOXYGUANIDINES AS INTEGRIN INHIBITORS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2001-12-05 | — | — | EP | disclosed |
| WO-2000047552-A1 | TYROSINE ALKOXYGUANIDINES AS INTEGRIN INHIBITORS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2000-08-17 | — | — | WO | disclosed |